Instituto de Investigaciones Biomédicas Alberto Sols-ko ikertzaileekin lankidetzan egindako argitalpenak (6)

2005

  1. Symmetrical bis-quinolinium compounds: New human choline kinase inhibitors with antiproliferative activity against the HT-29 cell line

    Journal of Medicinal Chemistry, Vol. 48, Núm. 9, pp. 3354-3363

2004

  1. Influence of the linker in bispyridium compounds on the inhibition of human choline kinase

    Journal of Medicinal Chemistry, Vol. 47, Núm. 22, pp. 5433-5440

2003

  1. Choline kinase inhibitory effect and antiproliferative activity of new 1,1′,1″-(benzene-1,3,5-triylmethylene)tris{4-[(disubstituted) amino]pyridinium} tribromides

    European Journal of Medicinal Chemistry, Vol. 38, Núm. 1, pp. 109-116

  2. Inhibition of choline kinase as a specific cytotoxic strategy in oncogene-transformed cells

    Oncogene, Vol. 22, Núm. 55, pp. 8803-8812

  3. QSAR-derived Choline Kinase inhibitors: How rational can antiproliferative drug design be?

    Current Medicinal Chemistry, Vol. 10, Núm. 13, pp. 1095-1112

1997

  1. Choline kinase inhibitors as a novel approach for antiproliferative drug design

    Oncogene, Vol. 15, Núm. 19, pp. 2289-2301